908 Devices Acquires NIRLAB AG

May 6, 2026

908 Devices, a Nasdaq-listed handheld chemical analysis company, completed its acquisition of NIRLAB AG, a privately held Swiss technology company specializing in AI-powered near-infrared (NIR) spectroscopy for narcotics identification. The deal adds an integrated NIR hardware and cloud subscription platform to expand 908 Devices' narcotics detection portfolio for fast, high-volume field screening.

Buyers
908 Devices Inc.
Targets
NIRLAB AG
Industry
Cybersecurity
Location
Vaud, Switzerland
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.